Abstract The catalytically competent Mn(II)-loaded form of the argE-encoded N-acetyl-L-ornithine deacetylase from Escherichia coli (ArgE) was characterized by kinetic, thermodynamic, and spectroscopic methods. Maximum Nacetyl-L-ornithine (NAO) hydrolytic activity was observed in the presence of one Mn(II) ion with k cat and K m values of 550 s -1 and 0.8 mM, respectively, providing a catalytic efficiency (k cat /K m ) of 6.9 · 10 5 M -1 s -1 . The ArgE dissociation constant (K d ) for Mn(II) was determined to be 0.18 lM, correlating well with a value obtained by isothermal titration calorimetry of 0.30 lM for the first metal binding event and 5.3 lM for the second. An Arrhenius plot of the NAO hydrolysis for Mn(II)-loaded ArgE was linear from 15 to 55°C, suggesting the rate-limiting step does not change as a function of temperature over this range. The activation energy, determined from the slope of this plot, was 50.3 kJ mol -1 . Other thermodynamic parameters were 
Introduction
The emergence of antibiotic-resistant bacterial infections has created a significant and growing medical problem in the USA and throughout the world [1] [2] [3] [4] . Antibiotic resistance has been recognized since the introduction of penicillin more than 50 years ago when penicillin-resistant infections caused by Staphylococcus aureus rapidly appeared [3, 5] . Because bacteria have been exposed to many of the currently available antibiotics, such as b-lactams, fluoroquinolones, macrolides, tetracyclines, aminoglycosides, glycopeptides, or trimethoprim combinations, for years, they have evolved resistance to these drugs [3, [6] [7] [8] [9] . In fact, several bacterial infections, some of which were thought to have been eradicated, have made a significant resurgence owing to bacterial resistance to antibiotics. These illnesses include, but are not limited to, tuberculosis, staph infections, and childhood bacterial meningitis or ear infections [3, 5] . In addition to its adverse effect on public health, antimicrobial resistance contributes to higher health care costs. Treating resistant infections often requires the use of more expensive or more toxic drugs, such as colistin, and can result in longer hospital stays for infected patients [10] . The Institute of Medicine, a part of the National Academy of Sciences, has estimated that the annual cost of treating antibiotic-resistant infections in the USA may be as high as $30 billion [1] . Since many of the broad-spectrum antibiotics contain b-lactam functional units that target enzymes involved in bacterial cell wall synthesis or pathways involved in cell replication [3, 5] , new enzymatic targets must be located so novel inhibitors can be synthesized, providing new classes of antibiotics. For this reason, several bacterial metallohydrolases containing dinuclear active sites have become the subject of intense efforts in inhibitor design [11] [12] [13] [14] [15] [16] . The argE-encoded N-acetyl-L-ornithine deacetylase (ArgE) is a bacterial metallohydrolase that contains a dinuclear active site and is a member of the arginine biosynthetic pathway in bacteria [17] . Prokaryotes synthesize arginine through a series of eight enzyme-catalyzed reactions that differ from those of eukaryotes in two key steps: (1) acetylation of glutamate and (2) the subsequent deacetylation of the arginine precursor N-acetyl-L-ornithine (NAO) by ArgE [18] . Because ornithine is required, not only for the synthesis of arginine in bacteria, but also for polyamines involved in DNA replication and cell division, NAO deacetylation is critical for bacterial proliferation [19] . Indeed, when Meinnel et al. [20] transformed an arginine auxotrophic bacterial strain void of NAO deacetylase activity with a plasmid containing argE, an Arg + phenotype resulted [20] . However, when the start codon (ATG) of argE in the same plasmid was changed to the Amber codon (TAG), the resultant plasmid was unable to relieve arginine auxotrophy in the same cell strain; therefore, ArgE is required for cell viability. Given the fact that ArgE is only found in prokaryotes and is required for bacterial cell growth and proliferation, it represents an enzymatic target for a novel class of antibacterial pharmaceuticals [19] .
Though little is currently known about ArgE, it shares high sequence homology with several dinuclear metallopeptidases in family M28, some of which have been characterized in detail using kinetic, spectroscopic, and crystallographic methods [21] . High-resolution X-ray crystal structures of the leucine aminopeptidase from Aeromonas proteolytica (Vibrio proteolyticus) (AAP) [22] and the carboxypeptidase G 2 from Pseudomonas sp. strain RS-16 (CPG 2 ) [23] revealed that these enzymes contain nearly identical active sites. To date, no X-ray crystallographic data have been reported for ArgE; however, all of the amino acids that function as metal ligands in AAP and CPG 2 are fully conserved in ArgE [21] . AAP and other M28 family members are competitively inhibited by synthetic small molecules classified as boronic acids [24] [25] [26] , chloromethyl ketones [27] , phosphonic acids [28] [29] [30] , hydroxamates [31] [32] [33] , and b-hydroxyamides [27] . The number of compounds isolated from natural sources capable of inhibiting aminopeptidases is also increasing. For instance, [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]leucine (bestatin), a dipeptide isolated from cultures of Streptomyces olivoreticuli [34] , exhibits slow-binding inhibition towards bovine lens leucine aminopeptidase (blLAP) and AAP with K i * values of 1.3 and 18 nM, respectively [35] . These small molecule inhibitors are effective owing to complexation of the active-site metal ions and this complexation is a function of both the particular metal ion involved and the catalytic mechanism of the enzyme. In order to determine if ArgE can be activated by Mn(II) ions, similar to blLAP [36] , we have examined the Mn(II)-loaded ArgE enzyme from Escherichia coli using both kinetic and spectroscopic methods. These data indicate that ArgE can be activated by Mn(II) ions and confirm that dinuclear Mn(II) centers are formed. These data also provide additional information regarding the enzymatic mechanism of ArgE, an important precursor to the rational design of a new class of ArgE inhibitors that potentially exhibit therapeutic functions.
Materials and methods

Enzyme expression and purification
All chemicals used in this study were purchased from commercial sources and were of the highest quality available. ArgE from E. coli was purified as previously described [17] from a stock culture provided by John Blanchard [21] . The purified enzyme exhibited a single band on a 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis gel, which corresponds to its calculated M r of 42,350, by comparison with molecular weight standards purchased from Sigma. It was subsequently concentrated to below 1 mM and stored at 4°C. Protein concentrations were determined using the theoretical value e 280 = 41,250 M -1 cm -1 [37] . 
where R = 1.9872 cal mol -1 K -1 . The relationship between K a and K d is defined as
Individual ArgE solutions were prepared by diluting stock enzyme solutions in 25 mM Chelex-100 treated HEPES buffer, pH 7.6, containing 150 mM KCl.
Spectroscopic measurements
Kinetic data were recorded using a Shimadzu UV-3101PC spectrophotometer. The temperature of assay solutions and that of the cuvette cavity were maintained by a circulating water bath (Isotemp 20130D, Fischer Scientific). Lowtemperature electron paramagnetic resonance (EPR) spectroscopy was performed using a Bruker Elexsys E500 spectrometer equipped with an ER 4116 DM dual-mode X-band cavity and an Oxford Instruments ESR-900 helium-flow cryostat. Background spectra recorded on a buffer sample were aligned with and subtracted from experimental spectra as described previously [38, 39] . EPR spectra were recorded with 20-mW microwave power (in a Bruker ER4116DM cavity in B microwave^Bstatic mode) at 9.6330 ± 0.0005 GHz, 6-30 K, and with 10.6 G magnetic field modulation at 100 kHz. 
where p is the number of sites for which interaction with Mn(II) is governed by the intrinsic dissociation constant, K d , and r is the binding function calculated by the conversion of the fractional saturation (f a ) using Eq. 4:
C S , the free metal concentration, was calculated using Eq. 5:
where C TS and C A are the total molar concentrations of metal and enzyme, respectively. A value for K d was obtained by fitting the data via an iterative process that allowed both K d and p to vary. The best fits obtained provided a p value of 1 and a K d value of 0.18 lM.
Isothermal titration calorimetry
ITC measurements were carried out using a MicroCal OMEGA ultrasensitive titration calorimeter at 25 ± 0.2°C. Association constants (K a ) were obtained by fitting these data, after subtraction of the background heat of dilution, via an interactive process using the Origin software package (Fig. 3) . The K a value, enzyme-metal stoichiometry (n), and the change in enthalpy (DH°) were allowed to vary during the fitting process. enzyme-catalyzed reaction were determined from an Arrhenius plot (Fig. 4a) . The activation energy (E a ) for [Mn(II)_(ArgE)] is 50.3 kJ mol -1 . Determination of E a in this manner allows subsequent resolution of other thermodynamic parameters by the following equations:
, where k B , h, and R are the Bolzmann, Planck and gas constants, respectively. Therefore, DG à = 58.1 kJ mol -1 , DH à = 47.8 kJ mol -1 , and DS à = -34.5 J mol -1 K -1 (Table 3) . Similarly, a plot of ln(1/K m ) versus inverse temperature is linear over the same temperature range (Fig. 4b) , so DH°was obtained as the negative slope times the gas constant. Since, DG°= RTln(1/K m ) and DS°= (DH°-DG°)/T, the following thermodynamic parameters were determined for the Michaelis complex of NAO: DG°= 0.5 kJ mol -1 , DH°= -65.0 kJ mol -1 , and DS°= -220.0 J mol -1 K -1 (Table 3) .
Inhibition of Mn(II)-loaded ArgE by bestatin
The effect of bestatin binding on the [Mn(II)_(ArgE)]-catalyzed NAO hydrolysis was examined. Four data sets of kinetic assays repeated in triplicates using six concentrations of NAO (0.1-2.0 mM) were collected at different bestatin concentrations (0-500 lM). (Fig. 6, spectrum B) . The origins of these fine-structure features were further explored by examining spectra of (1) [Mn(II)Mn(II)(ArgE)] recorded at different temperatures (Fig. 7) , (2) [Mn(II)Mn(II)(ArgE)] at pH 7.5 and pH 10.0 (Fig. 8) , (3) were distinct from that of [Mn(II)_(ArgE)] in that intense features due to fine structure were observable, though the spectra were different from each other and from that of [Mn(II)Mn(II)(ArgE)], particularly in terms of the intensities of the features at 4,000-5,000 G. The origin of the features in the spectra of the dimetallic forms of ArgE, other than the six-line g~2 pattern, were investigated via computer simulation (Fig. 9) . Subtraction of the spectrum of , and E/D = 0.05. The spectral density of the [Mn(II)Mn(II)(ArgE)] signal is asymmetric about the baseline in the 2,500-4,500-G region, suggesting rapid passage effects at the relatively high 
Discussion
The arginine biosynthetic pathway offers several potential antibacterial targets that have yet to be explored [19] . One of the members of this pathway, ArgE, has been identified in several pathogenic bacteria such as E. coli O157:H7, Salmonella typhimurium, Legionella pneumophila, Yersinia pseudotuberculosis, Bordetella pertussis, Vibrio cholerae, Staphylococcus aureus, and Mycobacterium tuberculosis [11, 20, 21, 42] . Alignment of each of the gene sequences with the structurally characterized dinuclear Zn(II) metallohydrolases AAP and GCP 2 revealed significant sequence homology, especially in the amino acids functioning as metal ligands [21] . However, it should be noted that no catalytically important amino acid residues have been identified for any ArgE enzyme. Both AAP and CPG 2 possess a (l-aquo)(l-carboxylato)dizinc(II) core with one terminal carboxylate and histidine residue bound to each metal ion [22, 23] . The enzymatic activity of the ArgE from E. coli has recently been shown to be dependent on Zn(II) ions similar to AAP and CPG 2 [17, 21] , but ArgE can also be activated by Mn(II) ions, unlike AAP and CPG 2 [17] . In an effort to gain insight into the structural and catalytic properties of ArgE, we examined the Mn(II)-loaded forms via kinetic, thermodynamic, and spectroscopic methods. ArgE shows nearly optimal kinetic activity in the presence of only 1 equiv of Mn(II). These data are similar to those reported for AAP, which exhibits approximately 90% of its total activity in the presence of one Zn(II) ion [43] . The k cat and K m values for ArgE loaded with 1 equiv of Mn(II) ([Mn(II)_(ArgE)]) were found to be 550 s -1 and 0.8 mM, respectively, providing a catalytic efficiency (k cat /K m ) of 6.9 · 10 5 M -1 s -1 . The k cat /K m value for Mn(II)-loaded ArgE is only 2.8 and 4.6 times smaller than that observed for the Zn(II)-loaded enzyme and the Co(II)-loaded enzyme, respectively, suggesting that Mn(II) provides an ArgE enzyme that is nearly as capable as the Zn(II)-loaded form. The fact that ArgE can be activated by a number of first-row transition metal ions in the divalent oxidation state is typical for metallohydrolases in the M28 family [11] . However, Mn(II) does not, in general, activate these enzymes. For example, AAP cannot be activated by Mn(II) [44] ; however, the dapE-encoded N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) from Haemophilus influenzae and blLAP, which is not a member of the M28 family, can both be activated by Mg(II) and Mn(II) [45] . ArgE shares no sequence homology with blLAP, but is 32% identical to AAP and retains all of the amino acid residues that function as metal ligands [21] . Such observations suggest ArgE may share structural homology with some enzymes and functional homology with others that are structurally distinct. Furthermore, the fact that ArgE is active with such a broad range of divalent metal ions suggests it might be critical to bacterial cell survival (i.e., if the cellular milieu is limiting in one metal, another can substitute).
Titration of apo-ArgE with Mn(II) confirmed that the enzyme is approximately 90% active after the addition of only 1 equiv of Mn(II). Fits of these titration data provided a K d value for the first metal binding site of 180 nM. Since only one metal ion is bound to the enzyme active site, these K d values correspond to the microscopic binding constants for the binding of a single metal ion to ArgE. This K d value is significantly smaller than that observed for Zn(II) binding to ArgE (6 lM), but is similar to K d values obtained for several other hydrolytic enzymes that contain mixed histidine-carboxylate active sites. For example, the K d values for the first Zn(II) ion binding events in DapE and AAP are 140 and 1 nM, respectively [45] . Verification of the observed K d value for the first metal binding site of ArgE was obtained from ITC. ITC measurements of Mn(II) binding to ArgE provided K d values of 300 nM for the first metal binding site and 5.3 lM for the second. These data indicate that Mn(II) binds 9 times more tightly to the first metal binding site and 10 times more tightly to the second metal binding site than Zn(II) [17] . These data suggest that under physiological conditions in the absence of substrate, the second metal binding site is potentially only occupied when Mn(II) ions are present. For Mn(II), the first and second metal binding events are both endothermic, which differs from the case for both Zn(II) and Co(II), which exhibit exothermic first metal binding events and endothermic second metal binding events [17] . Interestingly, the Gibbs free energy does not significantly change upon substitution of Zn(II) by Mn(II) or Co(II) and is similar to that observed for AAP. Similarly, the entropic factor (DS) remains the same for the first metal binding event despite a large decrease in K d for Mn(II) and Co(II) binding to ArgE. However, DS becomes negative for the second Mn(II) and Co(II) binding events but remains slightly positive for the second Zn(II) binding site. These data suggest a decrease in order around the second Mn(II) binding site.
Similar to AAP, ArgE binds 2 equiv of Mn(II), with DH 1 = 0.3 kJ mol -1 and DH 2 = 29.1 kJ mol -1 for AAP and DH 1 = 1.2 kJ mol -1 and DH 2 = 2.0 kJ mol -1 for ArgE. The binding affinity for Mn(II) at both sites on the basis of ITC measurements is similar for the two enzymes, K d1 = 3.4 lM and K d2 = 39 lM for AAP and K d1 = 0.3 lM and K d2 = 5.3 lM for ArgE. However, AAP is not catalytically competent when loaded with Mn(II) [44] . These data suggest that Mn(II) may bind to AAP and ArgE in a similar manner, but a Mn(II)-loaded AAP active site may not allow proper positioning of substrate for catalysis, while a Mn(II)-loaded ArgE site does. Thus, ArgE may also share functional homology with other dinuclear enzymes with which it shares little primary sequence homology, like the methionine aminopeptidase type II from Homo sapiens, which has been suggested to employ Mn(II) in vivo [46] . Therefore, efficacious pharmaceuticals targeting ArgE must incorporate functional groups that bind tightly and specifically to this active site in a variety of metal-loaded forms.
Since ArgE is relatively stable at 45°C, activation parameters for the ES à complex were obtained by examining the hydrolysis of NAO as a function of temperature. Construction of an Arrhenius plot from the temperature dependence of ArgE activity indicates that the rate-limiting step does not change as a function of temperature. therefore, the nature of M1 and that of M2 influence each other's electronic structures. Furthermore, the lack of direct magnetic interaction between the Mn(II) ions in [Mn(II)Mn(II)(ArgE)] suggests that the mechanisms of these intermetal effects are likely structural in nature rather than magnetic. Thus, the active-site geometry in ArgE appears to be unusually dependent on the precise metal complement; the fine structure in each of the spectra from Mn(II)-loaded forms of ArgE was all assignable to magnetically isolated Mn(II) ions by simulation (Fig. 9 ) and temperature dependence (Fig. 7) , and close examination of the fine structure (Fig. 8) . The positive enthalpy is indicative of a conformation change upon substrate binding, likely due to the energy of bond formation and breaking during nucleophilic attack on the scissile carbonyl carbon of the substrate. On the other hand, the negative entropy values suggest that some of the molecular motions are lost upon ES à complex formation, possibly owing to hydrogen-bond formation between catalytically important amino acids and the substrate. All of these factors contribute to the large positive free energy of activation.
Peptide analog inhibitors of microbiological origin have not been examined with an ArgE enzyme, but one of these, bestatin, has been shown to be a competitive, slow-binding inhibitor of both blLAP and AAP, with K i * values of 1.3 and 18 nM, respectively [35, 41, 52] . Bestatin is a naturally occurring dipeptide isolated from cultures of S. olivoreticuli and the metal binding region of bestatin has been designed into numerous dinuclear metallohydrolase inhibitors [52] . X-ray crystallographic data of bestatin-bound complexes of blLAP and AAP have been reported [53, 54] . The X-ray crystal structures of both [Zn(II)Zn(II)(blLAP)]-bestatin and [Zn(II)Zn(II)(AAP)]-bestatin revealed that the N-terminal amino group of bestatin coordinates to Zn2, while the alkoxide moiety bridges between the two Zn(II) ions. Interestingly, the backbone carbonyl oxygen of bestatin is not bound to the dinuclear metal center in blLAP but is, instead, hydrogen-bonded to the positively charged terminal amine of an active-site lysine residue. However, in AAP the backbone carbonyl oxygen of bestatin binds to Zn1. In order to determine if the metal binding region of bestatin can bind to the dinuclear active site of ArgE, the K i for bestatin binding to Mn(II)-loaded ArgE was measured. Bestatin was found to be a simple competitive inhibitor of [Mn(II)Mn(II)(ArgE)], with a K i of 67 lM. The presence or absence of a bridging water/hydroxide in the active site of Mn(II)-loaded ArgE was investigated by binding bestatin to [Mn(II)Mn(II)(ArgE)]. Only mild perturbation of the signal was observed in the EPR spectrum with bestatin, indicating binding to the active site, but not in a way that perturbs exchange coupling. These data indicate that bestatin binds to ArgE in a significantly different way from how it binds to AAP or blLAP [53, 54] . While bestatin does not bind ArgE tightly or specifically enough to be therapeutically practical, this dipeptide provides a backbone from which other molecules may be synthesized with increased and more specific binding affinity to the ArgE active site.
In conclusion, the kinetic and thermodynamic data presented herein provide evidence that two Mn(II) ions can bind to ArgE with K d values that differ by a factor of approximately 18. Moreover, ArgE is nearly fully active upon the addition of one divalent Mn(II) ion. Therefore, ArgE behaves similarly to AAP where one metal ion is the catalytic metal ion, while the second is likely to play a structural role [47] . The spectroscopic data presented herein provide the first structural glimpse at the active site of a Mn(II)-loaded ArgE enzyme. EPR spectra of [Mn(II)Mn(II)(ArgE)] indicate clear evidence of spin-spin coupling between the two Mn(II) ions, but only at high pH values. In addition, bestatin was shown to be a competitive inhibitor of ArgE, but on the basis of EPR data, no bridging alkoxide moiety is present in the dimanganese(II) active site of ArgE. These data suggest that bestatin binds to ArgE enzymes in a way different from that observed by X-ray crystallography for AAP and blLAP [53, 54] . This finding is critical for the future design and synthesis of small molecule inhibitors, based on the metal binding components of bestatin that potentially target ArgE enzymes.
